Last reviewed · How we verify
NCT06797050: LbyT
A Story for Pepper & Nao
NA trial testing Training in reordering figurative stories with a social robot through the Learning by Teaching approach in Children and Adolescents With Neuromotor Impairment in 80 participants. Currently enrolling.
1 September 2026
Quick facts
| Lead sponsor | IRCCS Fondazione Stella Maris |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 April 2025 |
| Primary completion | 1 September 2026 |
| Estimated completion | 30 October 2026 |
| Sites | 3 locations across Italy |
Drugs / interventions tested
- Training in reordering figurative stories with a social robot through the Learning by Teaching approach
Conditions studied
- Children and Adolescents With Neuromotor Impairment — all drugs for Children and Adolescents With Neuromotor Impairment →
Sponsor
IRCCS Fondazione Stella Maris — full company profile →
Who can join
Adults 7 to 16, any sex, with Children and Adolescents With Neuromotor Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study is to improve cognitive processes that are frequently impaired in children characterised by neuromotor impairment, such as the skills of visual-perceptual analysis and selective attention, working memory, narrative organisation, logical-inferential reasoning and motor planning. For this purpose, a task of reordering figurative stories and action sequences, which include the aforementioned processes, will be used through an innovative Learning by Teaching training paradigm with a social robot. Furthermore, the study aims to verify the children's level of behavioural, cognitive and emotional engagement during the interaction with the social robot and to test the generalisation effects of the intervention on other processes, such as working memory, inhibition and planning.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06797050
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Children and Adolescents With Neuromotor Impairment
Currently open trials in the same condition.
- NCT07307950 — "Healthcare APPlication for Children and Young People With Neuromotor Disabilities": a Digital Tool to Promote Integrate · recruiting
Other IRCCS Fondazione Stella Maris trials
Trials by the same sponsor.
- NCT07207213 — SOCIAL: Adaptation and Validation of the In-person PEERS® Program for Adolescents With Autism. · NA · not yet recruiting
- NCT06826287 — 7T Anatomo-functional Characterization of Structures in the Action Observation Network · recruiting
- NCT06666829 — Multicenter Study That Offers New Solutions for Paediatric Rehabilitation by Proposing a Rehabilitation Plan Based on Ea · NA · recruiting
- NCT06817746 — Telehealth Intervention for Infants With Prodromes of ASD · NA · recruiting
- NCT06672731 — BIOchemical, DEnsitometric, TEChnological and Imaging Tools to Evaluate the Bone/muscle in Children with Cerebral Palsy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06797050 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Fondazione Stella Maris
- Last refreshed: 2 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06797050.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing